2024 ICD-10-PCS Procedure Code XW0DXJ9
Introduction of Quizartinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 9 Code History Convert XW0DXJ9 to ICD-9-CM
Introduction of Quizartinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 9 Code History Convert XW0DXJ9 to ICD-9-CM
Introduction of Melphalan Hydrochloride Antineoplastic into Peripheral Artery, Percutaneous Approach, New Technology Group 9 Code History Convert XW053T9 to ICD-9-CM
Introduction of Rezafungin into Central Vein, Percutaneous Approach, New Technology Group 9 Code History Convert XW043R9 to ICD-9-CM
Introduction of Posoleucel into Central Vein, Percutaneous Approach, New Technology Group 9 Code History Convert XW043Q9 to ICD-9-CM
Introduction of Glofitamab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 9 Code History Convert XW043P9 to ICD-9-CM
Introduction of Sulbactam-Durlobactam into Central Vein, Percutaneous Approach, New Technology Group 9 Code History Convert XW043K9 to ICD-9-CM
Introduction of Rezafungin into Peripheral Vein, Percutaneous Approach, New Technology Group 9 Code History Convert XW033R9 to ICD-9-CM
Introduction of Posoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 9 Code History Convert XW033Q9 to ICD-9-CM
Introduction of Glofitamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 9 Code History Convert XW033P9 to ICD-9-CM
Introduction of Sulbactam-Durlobactam into Peripheral Vein, Percutaneous Approach, New Technology Group 9 Code History Convert XW033K9 to ICD-9-CM